|
Shahan, Tracy; Grant, Derrick; Tootell, Mason et al. (2004) Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis. Connect Tissue Res 45:151-63
|
|
Lin, Xiaoqing; Lubinski, John M; Friedman, Harvey M (2004) Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol 78:2562-71
|
|
Rex, Tonia S; Allocca, Mariacarmela; Domenici, Luciano et al. (2004) Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther 10:855-61
|
|
Fawzi, A; Robinet, A; Monboisse, J C et al. (2000) A peptide of the alpha 3(IV) chain of type IV collagen modulates stimulated neutrophil function via activation of cAMP-dependent protein kinase and Ser/Thr protein phosphatase. Cell Signal 12:327-35
|
|
Shahan, T A; Fawzi, A; Bellon, G et al. (2000) Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(V)beta(3). J Biol Chem 275:4796-802
|
|
Pasco, S; Han, J; Gillery, P et al. (2000) A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells. Cancer Res 60:467-73
|
|
Li, D; Clark, C C; Myers, J C (2000) Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J Biol Chem 275:22339-47
|
|
Shahan, T A; Ohno, N; Pasco, S et al. (1999) Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP. Connect Tissue Res 40:221-32
|
|
Shahan, T A; Ziaie, Z; Pasco, S et al. (1999) Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Cancer Res 59:4584-90
|
|
Ziaie, Z; Kefalides, N A (1999) Inhibition of polymorphonuclear leukocyte activation by acetylcholinesterase. Mol Cell Biol Res Commun 2:11-4
|
Showing the most recent 10 out of 30 publications
